Terms: = Bone cancer AND FUS, P35637, 2521, ENSG00000089280, TLS/CHOP, FUS-CHOP, CHOP, FUS1, TLS AND Treatment
325 results:
1. Role of plasma EBV-DNA load and EBER status on newly diagnosed peripheral T-cell lymphoma.
Chen J; Zhou J; Cheng F; Chen D; Guan F; Zhang E; He J; Cai Z; Zhao Y
J Cancer Res Clin Oncol; 2024 Apr; 150(4):181. PubMed ID: 38587664
[TBL] [Abstract] [Full Text] [Related]
2. Expression of the chemokine receptor CCR1 decreases sensitivity to bortezomib in multiple myeloma cell lines.
Zeissig MN; Hewett DR; Mrozik KM; Panagopoulos V; Wallington-Gates CT; Spencer A; Dold SM; Engelhardt M; Vandyke K; Zannettino ACW
Leuk Res; 2024 Apr; 139():107469. PubMed ID: 38479337
[TBL] [Abstract] [Full Text] [Related]
3. Primary thyroid lymphoma: a case series.
Sakhri S; Zemni I; Ayadi MA; Kamoun S; Chargui R; Ben Dhiab T
J Med Case Rep; 2024 Feb; 18(1):108. PubMed ID: 38395921
[TBL] [Abstract] [Full Text] [Related]
4. [Successful cord blood transplantation for refractory gamma-delta hepatosplenic T-cell lymphoma developed during treatment of Crohn's disease].
Saito A; Nara M; Fujishima T; Kuroki W; Yamashita T; Kobayashi T; Ikeda S; Kitadate A; Kameoka Y; Takahashi N
Rinsho Ketsueki; 2024; 65(1):41-46. PubMed ID: 38311388
[TBL] [Abstract] [Full Text] [Related]
5. Long-term outcomes with HLX01 (HanliKang
Qin Y; Song Y; Wang D; Bai O; Feng J; Sun X; Qiu L; Yang J; Yang Y; Wang Z; Hu J; Wang H; Su H; Jin Z; Qian W; Jin C; Zhang M; Yu D; Liu L; Chen G; Li Y; Sun T; Jin J; Bao H; Du X; Zhou H; Fu G; Shi Y
BMC Cancer; 2024 Jan; 24(1):124. PubMed ID: 38267866
[TBL] [Abstract] [Full Text] [Related]
6. Vascular Neoplasms With NFATC1/C2 Gene Alterations : Expanding the Clinicopathologic and Molecular Characteristics of a Distinct Entity.
Dashti NK; Perret R; Balzer B; Naous R; Michal M; Dermawan JK; Antonescu CR
Am J Surg Pathol; 2024 Apr; 48(4):487-496. PubMed ID: 38189436
[TBL] [Abstract] [Full Text] [Related]
7. Genetic Characterization of Primary Mediastinal B-Cell Lymphoma: Pathogenesis and Patient Outcomes.
Noerenberg D; Briest F; Hennch C; Yoshida K; Hablesreiter R; Takeuchi Y; Ueno H; Staiger AM; Ziepert M; Asmar F; Locher BN; Toth E; Weber T; Amini RM; Klapper W; Bouzani M; Poeschel V; Rosenwald A; Held G; Campo E; Ishaque N; Stamatopoulos K; Kanellis G; Anagnostopoulos I; Bullinger L; Goldschmidt N; Zinzani PL; Bödör C; Rosenquist R; Vassilakopoulos TP; Ott G; Ogawa S; Damm F
J Clin Oncol; 2024 Feb; 42(4):452-466. PubMed ID: 38055913
[TBL] [Abstract] [Full Text] [Related]
8. The impact of chop versus bendamustine on bone mineral density in patients with indolent lymphoma enrolled in the GALLIUM study.
Pedersen MA; Gormsen LC; Jakobsen LH; Eyre TA; Severinsen MT; Baech J; Dann EJ; Knapp A; Sahin D; Vestergaard P; El-Galaly TC; Jensen P
Br J Haematol; 2024 Apr; 204(4):1271-1278. PubMed ID: 37957542
[TBL] [Abstract] [Full Text] [Related]
9. Clinicopathologic and mutational profiles of primary breast diffuse large B cell lymphoma in a male patient: case report and literature review.
Huang F; Ruan Y; He X; Lian H; Yang J
World J Surg Oncol; 2023 Oct; 21(1):342. PubMed ID: 37884941
[TBL] [Abstract] [Full Text] [Related]
10. Intraosseous Spindle Cell Rhabdomyosarcoma with
Smith BF; Doung YC; Beckett B; Corless CL; Davis LE; Davis JL
Cancer Invest; 2023 Sep; 41(8):704-712. PubMed ID: 37668330
[TBL] [Abstract] [Full Text] [Related]
11. Successes and Challenges in Taming the Beast: Cytotoxic Immune Effectors in Amyotrophic Lateral Sclerosis.
Kaur K; Chen PC; Ko MW; Mei A; Huerta-Yepez S; Maharaj D; Malarkannan S; Jewett A
Crit Rev Immunol; 2023; 43(1):1-11. PubMed ID: 37522557
[TBL] [Abstract] [Full Text] [Related]
12. Metformin sensitizes AML cells to venetoclax through endoplasmic reticulum stress-chop pathway.
Hua L; Yang N; Li Y; Huang K; Jiang X; Liu F; Yu Z; Chen J; Lai J; Du J; Zeng H
Br J Haematol; 2023 Sep; 202(5):971-984. PubMed ID: 37409755
[TBL] [Abstract] [Full Text] [Related]
13. Hepatosplenic T-cell lymphoma presented with massive splenomegaly and pancytopenia - a case report.
Sukrisman L; Rajabto W; Harahap AS; Fanggidae ESDE; Ham MF; Priantono D
Klin Onkol; 2023; 36(3):246-250. PubMed ID: 37353354
[TBL] [Abstract] [Full Text] [Related]
14. Rituximab versus obinutuzumab-based first-line chemoimmunotherapy for follicular lymphoma-a real-world multicenter retrospective cohort study.
Berger T; Shochat T; Aumann S; Nachmias B; Goldschmidt N; Horesh N; Harel R; Aviv A; Shmerts E; Abadi U; Shimony S; Raanani P; Gafter-Gvili A; Gurion R
Ann Hematol; 2023 Aug; 102(8):2127-2136. PubMed ID: 37335322
[TBL] [Abstract] [Full Text] [Related]
15. Successful Prevention of Tumour Lysis Syndrome in HER2-positive Breast cancer: Case Report and Literature Review.
Omori S; Shigechi T; Kawaguchi K; Ijichi H; Oki E; Yoshizumi T
Anticancer Res; 2023 May; 43(5):2371-2377. PubMed ID: 37097695
[TBL] [Abstract] [Full Text] [Related]
16. Clinicopathological and Molecular Characteristics of Intraosseous Rhabdomyosarcoma Involving Head and Neck Region: A Systematic Review and Meta-Analysis.
Sivakumar N; Sharma P; Chandra S; Gupta S; Samadi FM; Baghel S
Pediatr Dev Pathol; 2023; 26(3):299-309. PubMed ID: 37082926
[TBL] [Abstract] [Full Text] [Related]
17. TP53 mutations identify high-risk events for peripheral T-cell lymphoma treated with chop-based chemotherapy.
Johnson WT; Ganesan N; Epstein-Peterson ZD; Moskowitz AJ; Stuver RN; Maccaro CR; Galasso N; Chang T; Khan N; Aypar U; Lewis NE; Zelenetz AD; Palomba ML; Matasar MJ; Noy A; Hamilton AM; Hamlin P; Caron PC; Straus DJ; Intlekofer AM; Lee Batlevi C; Kumar A; Owens CN; Sauter CS; Falchi L; Lue JK; Vardhana SA; Salles G; Dogan A; Schultz ND; Arcila ME; Horwitz SM
Blood Adv; 2023 Sep; 7(17):5172-5186. PubMed ID: 37078708
[TBL] [Abstract] [Full Text] [Related]
18. Long-term clinical evidence of comparable efficacy and toxicity of nivolumab and pembrolizumab in advanced melanoma treatment.
Cybulska-Stopa B; Piejko K; Ostaszewski K; Dziura R; Galus Ł; Ziółkowska B; Kempa-Kamińska N; Ziętek M; Bal W; Kamycka A; Dudzisz-Śledź M; Kubiatowski T; Kamińska-Winciorek G; Suwiński R; Mackiewicz J; Czarnecka AM; Rutkowski P
Melanoma Res; 2023 Jun; 33(3):208-217. PubMed ID: 37015054
[TBL] [Abstract] [Full Text] [Related]
19. Evaluation of a Developed MRI-Guided Focused Ultrasound System in 7 T Small Animal MRI and Proof-of-Concept in a Prostate cancer Xenograft Model to Improve Radiation Therapy.
Zhang X; Greiser S; Roy U; Lange F; van Gorkum R; Fournelle M; Speicher D; Tretbar S; Melzer A; Landgraf L
Cells; 2023 Feb; 12(3):. PubMed ID: 36766824
[TBL] [Abstract] [Full Text] [Related]
20. Propofol Regulates ER Stress to Inhibit Tumour Growth and Sensitize Osteosarcoma to Doxorubicin.
Wei H; Du X; Zhao H; Sun P; Yang J
Int J Clin Pract; 2023; 2023():3093945. PubMed ID: 36756222
[TBL] [Abstract] [Full Text] [Related]
[Next]
